Vol. 61 No. 10 (2022): Acta Oncologica

Articles

• End-of-life care of patients with esophageal or gastric cancer: decision making and the goal of care

  Pauliina M. Kitti, Anu M. Anttonen, Riikka-Leena Leskelä, Tiina Saarto

  1173-1178

  Published: 2022-10-03

  • PDF

• Periodic trends in geographical variation of prostate cancer incidence and mortality in Finland between 1985 and 2019

  Heikki Seikkula, Antti Kaipia, Peter J. Boström, Nea Malila, Janne Pitkäniemi, Karri Seppä

  1209-1215

  Published: 2022-10-03

  • PDF

• The clinical value of C-reactive protein and its association with tumour location in patients undergoing curative surgery for colorectal cancer – a ScotScan collaborative study

  Anniken J. Fuglestad, Sebastian Meltzer, Anne Hansen Ree, Donald C. McMillan, James H. Park, Christian Kersten

  1248-1255

  Published: 2023-10-16

  • PDF

• Recurrence rate after radical prostatectomy following primary staging of high-risk prostate cancer with 68Ga-PSMA PET/CT

  Søren Klingenberg, Jacob Fredsøe, Karina D. Sørensen, Benedicte P. Ulhøi, Michael Borre, Mads R. Jochumsen, Kirsten Bouchelouche

  1289-1294

  Published: 2022-10-03

  • PDF

• Late effects – the new focus of follow-up

  Christoffer Johansen, Annika von Heymann, Bolette S. Rafn, Signe Borgquist, Peer Christiansen, Peter Christensen, Robert Zachariae, Helle Pappot, Ulrik Lassen

  1163-1164

  Published: 2022-10-03

  • PDF

• Diet and bowel symptoms among colon cancer survivors

  Mette Borre, Janne Fassov, Therese Juul, Søren Laurberg, Peter Christensen, Annette Boesen Bräuner, Ole Thorlacius Ussing, Michael Bødker Lauritzen, Asbjørn Mohr Drewes, Pia Møller Faaborg, Klaus Krogh

  1192-1199

  Published: 2022-10-03

  • PDF

• Prospective study of Na[18F]F PET/CT for cancer staging in morbidly obese patients compared with [99mTc]Tc-MDP whole-body planar, SPECT and SPECT/CT

  Sharjeel Usmani, Najeeb Ahmed, Gopinath Gnanasegaran, Fareeda Al kandari, Fahad Marafi, Ahmed Bani-Mustafa, Ahmed Musbah, Maryam Jassem Almashmoum, Tim Van den Wyngaert

  1230-1239

  Published: 2022-10-03

  • PDF

• Molecular analysis and favorable clinical outcomes in real-world patients with metastatic renal cell carcinoma

  Frede Donskov, Cathy Anne Pinto, Raluca Predoiu, Claire Fox, Jeanette Baehr Georgsen, Katrine Skaarup, Mehmet Burcu, Rodolfo Perini, Torben Steiniche

  1268-1277

  Published: 2022-10-03

  • PDF

• High levels of health-related quality of life five years after curative treatment of prostate cancer with HDR-brachytherapy and external beam radiation

  Marie Hjälm-Eriksson, Anders Ullén, Sten Nilsson, Hemming Johansson, Josef Nilsson, Enrique Castellanos, Yvonne Brandberg

  1179-1185

  Published: 2022-10-03

  • PDF

• Cancer-related costs should be allocated in a comparable way—benchmarking costs of cancer in Nordic countries 2012–2017

  Paulus Torkki, Riikka-Leena Leskelä, Christoffer Bugge, Johanna Eyrun Torfadottir, Sakari Karjalainen

  1216-1222

  Published: 2022-10-03

  • PDF

• Increased use of computed tomography in Denmark: stage shift toward early stage lung cancer through incidental findings

  M. Borg, O. Hilberg, M. B. Andersen, U. M. Weinreich, T. R. Rasmussen

  1256-1262

  Published: 2022-10-03

  • PDF

• Toxic epidermal necrolysis after immune checkpoint inhibition, case report, and review of the literature

  Hanne Sommerfelt, Lene F. Sandvik, Ingeborg M. Bachmann, Ragnvald Ljones Brekke, Henrik Løvendahl Svendsen, Anne Berit Guttormsen, Sura Aziz, Hanna Dillekås, Oddbjørn Straume

  1295-1299

  Published: 2022-10-03

  • PDF

• Prevalence and risk factors for sexual dysfunction in young women following a cancer diagnosis – a population-based study

  Lena Wettergren, Lars E. Eriksson, Charlotta Bergström, Christel Hedman, Johan Ahlgren, Karin E. Smedby, Kristina Hellman, Roger Henriksson, Claudia Lampic

  1165-1172

  Published: 2022-10-03

  • PDF

• Factors predicting long-term physical activity of breast cancer survivors. 5-year-follow-up of the BREX exercise intervention study

  Kristiina Kokkonen, Pirkko-Liisa Kellokumpu-Lehtinen, Markku Kankaanpää, Riku Nikander, Heidi Maria Penttinen, Meri Utriainen, Leena Vehmanen, Riikka Huovinen, Hannu Kautiainen, Carl Blomqvist, Tiina Saarto

  1200-1208

  Published: 2022-10-03

  • PDF

• C-reactive protein and immune-related adverse events as prognostic biomarkers in immune checkpoint inhibitor treated metastatic renal cell carcinoma patients

  Elisa Kankkunen, Patrick Penttilä, Katriina Peltola, Petri Bono

  1240-1247

  Published: 2022-10-03

  • PDF

• Temporal development in survival, and gender and regional differences in the Swedish population of patients with synchronous and metachronous metastatic colorectal cancer

  Emerik Osterlund, Bengt Glimelius

  1278-1288

  Published: 2022-10-03

  • PDF

• Caregiver burden and health-related quality of life among family caregivers of oesophageal cancer patients: a prospective nationwide cohort study

  Anna Schandl, Cecilia Ringborg, Kalle Mälberg, Asif Johar, Pernilla Lagergren

  1186-1191

  Published: 2022-10-03

  • PDF

• Circulating DNA in the neoadjuvant setting of early stage colon cancer

  Giacomo Bregni, Andrea Pretta, Chiara Senti, Elena Acedo Reina, Caroline Vandeputte, Elena Trevisi, Paraskevas Gkolfakis, Pashalina Kehagias, Jean-Luc Van Laethem, Philippe Vergauwe, Marc Van den Eynde, Guido Deboever, Jos Janssens, Gauthier Demolin, Stephane Holbrechts, Marylene Clausse, Thierry De Grez, Marc Peeters, Lionel D'Hondt, Karen Geboes, Tatiana Besse-Hammer, Françoise Rothé, Patrick Flamen, Alain Hendlisz, Francesco Sclafani, Amélie Deleporte

  1223-1229

  Published: 2022-10-03

  • PDF

• Circulating tumor DNA is a prognostic biomarker in metastatic melanoma patients treated with chemoimmunotherapy and BRAF inhibitor

  Kalle E. Mattila, Siru Mäkelä, Soili Kytölä, Emma Andersson, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, Kristiina Aittomäki, Micaela Hernberg

  1263-1267

  Published: 2022-10-03

  • PDF